SMLR Key Statistics, Chart & Performance
The current stock price of SMLR is 19.98 USD. In the past month the price decreased by -21.37%. In the past year, price decreased by -67.64%.
SMLR Latest News, Press Relases and Analysis
SMLR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.31 | 219.65B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.94 | 201.26B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.57 | 146.79B | ||
| SYK | STRYKER CORP | 27.84 | 140.23B | ||
| IDXX | IDEXX LABORATORIES INC | 58.11 | 58.51B | ||
| BDX | BECTON DICKINSON AND CO | 13.21 | 54.59B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.96 | 49.16B | ||
| RMD | RESMED INC | 25.34 | 36.62B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.48 | 36.54B | ||
| DXCM | DEXCOM INC | 34.65 | 25.14B | ||
| PODD | INSULET CORP | 67.61 | 21.74B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.64 | 18.66B |
Related stock screener links
About SMLR
Company Profile
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Campbell, California and currently employs 79 full-time employees. The company went IPO on 2014-02-27. The firm's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The firm delivers QuantaFlo directly to its customers. The firm also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
Company Info
SEMLER SCIENTIFIC INC
51 E Campbell Ave, Suite 107-D
Campbell CALIFORNIA 97210 US
CEO: Douglas Murphy-Chutorian
Employees: 79
Phone: 18777744211
SEMLER SCIENTIFIC INC / SMLR FAQ
What does SEMLER SCIENTIFIC INC do?
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Campbell, California and currently employs 79 full-time employees. The company went IPO on 2014-02-27. The firm's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The firm delivers QuantaFlo directly to its customers. The firm also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
What is the current price of SMLR stock?
The current stock price of SMLR is 19.98 USD. The price increased by 1.16% in the last trading session.
Does SEMLER SCIENTIFIC INC pay dividends?
SMLR does not pay a dividend.
What is the ChartMill rating of SEMLER SCIENTIFIC INC stock?
SMLR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists SMLR stock?
SMLR stock is listed on the Nasdaq exchange.
Can you provide the ownership details for SMLR stock?
You can find the ownership structure of SEMLER SCIENTIFIC INC (SMLR) on the Ownership tab.
What is the Short Interest ratio of SEMLER SCIENTIFIC INC (SMLR) stock?
The outstanding short interest for SEMLER SCIENTIFIC INC (SMLR) is 16.53% of its float.
SMLR Technical Analysis
SMLR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SMLR. While SMLR has a great profitability rating, there are quite some concerns on its financial health.
SMLR Financial Highlights
Over the last trailing twelve months SMLR reported a non-GAAP Earnings per Share(EPS) of 8.76. The EPS increased by 220.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 86.2% | ||
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| Debt/Equity | 0.25 |
SMLR Forecast & Estimates
9 analysts have analysed SMLR and the average price target is 76.84 USD. This implies a price increase of 284.58% is expected in the next year compared to the current price of 19.98.
For the next year, analysts expect an EPS growth of -95.59% and a revenue growth -43.54% for SMLR